Active Surveillance of Thyroid Microcarcinomas: a Critical View

Imagem de Miniatura
Arquivos
art_CERNEA_Active_Surveillance_of_Thyroid_Microcarcinomas_a_Critical_View_2022.PDF (1006.02 KB)
Citações na Scopus
7
Tipo de produção
article
Data de publicação
2022
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER
Autores
Citação
CURRENT ONCOLOGY REPORTS, v.24, n.1, p.69-76, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Purpose of the Review There has been an increasing interest on active surveillance for papillary thyroid microcarcinomas (PTMC) in the literature. We will analyze the contributions of those authors who support this approach in most patients with low-risk tumors. Recent Findings The development of molecular methods to effectively detect aggressive PTMC at the fine-needle aspiration biopsy will enable the sound indication of immediate surgery in those patients, assuring the other individuals with the far more frequent indolent PTMC will undergo active surveillance with less anxiety. Several studies compared the quality of life between patients with PTMC who underwent active surveillance with immediate total thyroidectomy. However, thyroid lobectomy is a quite acceptable intermediate alternative for most patients with PTMC, with less surgical morbidity. Summary It is important to wait for worldwide validation, with reports from low- and middle-income areas, before recommending the routine adoption of active surveillance for patients with PTMC, due to difficult logistic obstacles in those environments.
Palavras-chave
Thyroid cancer, Papillary, Papillary thyroid microcarcinoma, Watchful waiting, Active surveillance, Prognosis
URI
https://observatorio.fm.usp.br/handle/OPI/45814
Referências
  1. Bastos AU, 2015, EUR J ENDOCRINOL, V173, P525, DOI 10.1530/EJE-15-0254
  2. Carling T, 2007, WORLD J SURG, V31, P916, DOI 10.1007/s00268-006-0837-3
  3. Cernea CR, 2019, ARCH ENDOCRIN METAB, V63, P453, DOI 10.20945/2359-3997000000181
  4. Choi JS, 2009, AM J ROENTGENOL, V193, P871, DOI 10.2214/AJR.09.2386
  5. Cibas ES, 2009, AM J CLIN PATHOL, V132, P658, DOI 10.1309/AJCPPHLWMI3JV4LA
  6. D'Agostino TA, 2018, PSYCHO-ONCOLOGY, V27, P61, DOI 10.1002/pon.4383
  7. Esserman LJ, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.k4699
  8. Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020
  9. Hwang HS, 2011, LARYNGOSCOPE, V121, P487, DOI 10.1002/lary.21227
  10. Ito Y, 2003, THYROID, V13, P381, DOI 10.1089/105072503321669875
  11. Ito Y, 2007, NAT CLIN PRACT ENDOC, V3, P240, DOI 10.1038/ncpendmet0428
  12. Ito Y, 2018, THYROID, V28, P488, DOI 10.1089/thy.2017.0448
  13. Ito Y, 2016, ENDOCR J, V63, P323, DOI 10.1507/endocrj.EJ15-0637
  14. Ito Y, 2016, WORLD J SURG, V40, P523, DOI 10.1007/s00268-015-3184-4
  15. Ito Y, 2014, THYROID, V24, P27, DOI 10.1089/thy.2013.0367
  16. Ito Y, 2010, WORLD J SURG, V34, P2333, DOI 10.1007/s00268-010-0712-0
  17. Khokhar MT, 2015, THYROID, V25, P1351, DOI 10.1089/thy.2015.0176
  18. Kocher, 1909, CONCERNING PATHOLOGI
  19. Kocher ET, 1883, ARCH KLIN CHIR, V29, P254
  20. Kuo EJ, 2013, THYROID, V23, P1305, DOI 10.1089/thy.2012.0563
  21. Lesnik D, 2014, HEAD NECK-J SCI SPEC, V36, P191, DOI 10.1002/hed.23277
  22. Li DP, 2016, J CELL BIOCHEM, V117, P1491, DOI 10.1002/jcb.25506
  23. Li F, 2015, ENDOCR-RELAT CANCER, V22, P159, DOI 10.1530/ERC-14-0531
  24. Lin JF, 2020, SURGERY, V167, P110, DOI 10.1016/j.surg.2019.05.078
  25. Lohia S, 2020, LARYNGOSCOPE INVEST, V5, P175, DOI 10.1002/lio2.356
  26. Miyauchi A, 2019, SURGERY, V165, P25, DOI 10.1016/j.surg.2018.07.045
  27. Molinaro E, 2020, J CLIN ENDOCR METAB, V105, pE172, DOI 10.1210/clinem/dgz113
  28. Moon JH, 2018, ENDOCRINOL METAB, V33, P278, DOI 10.3803/EnM.2018.33.2.278
  29. Nickel B, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4152-9
  30. Nickel B, 2017, THYROID, V27, P661, DOI 10.1089/thy.2016.0483
  31. Niemeier LA, 2012, CANCER-AM CANCER SOC, V118, P2069, DOI 10.1002/cncr.26425
  32. Oda H, 2016, THYROID, V26, P150, DOI 10.1089/thy.2015.0313
  33. Oh HS, 2018, THYROID, V28, P1587, DOI 10.1089/thy.2018.0263
  34. Pollack R, 2021, J SURG RES, V258, P145, DOI 10.1016/j.jss.2020.08.061
  35. Reinke R, 2019, CANCER EPIDEMIOL, V60, P46, DOI 10.1016/j.canep.2019.03.011
  36. Ross DS, 2014, THYROID, V24, P3, DOI 10.1089/thy.2013.0659
  37. Sakai T, 2019, THYROID, V29, P59, DOI 10.1089/thy.2018.0462
  38. Sawka AM, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020298
  39. Schumm MA, 2021, SURGERY, V169, P282, DOI 10.1016/j.surg.2020.08.019
  40. Shih PT, 2021, THYROID, V31, P1067, DOI 10.1089/thy.2020.0694
  41. Siddiqui S, 2016, THYROID, V26, P807, DOI 10.1089/thy.2015.0429
  42. Silver CE, 2011, HEAD NECK-J SCI SPEC, V33, P1052, DOI 10.1002/hed.21494
  43. Smulever A, 2021, ENDOCRINE, V72, P505, DOI 10.1007/s12020-020-02566-0
  44. Stack BC, 2015, JAMA OTOLARYNGOL, V141, P957, DOI 10.1001/jamaoto.2015.2419
  45. Sugitani I, 2021, THYROID, V31, P183, DOI 10.1089/thy.2020.0330
  46. Tuttle RM, 2017, JAMA OTOLARYNGOL, V143, P1015, DOI 10.1001/jamaoto.2017.1442
  47. Xue S, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00736
  48. Yabuta T, 2017, THYROID, V27, P1206, DOI 10.1089/thy.2016.0645
  49. Zanocco KA, 2019, JAMA-J AM MED ASSOC, V321, P2020, DOI 10.1001/jama.2019.5350

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCG
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/02
Artigos e Materiais de Revistas Científicas - LIM/08
Artigos e Materiais de Revistas Científicas - LIM/28
Carregar mais